Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7809]

ASCO 2016: Lenalidomide maintenance therapy improves overall survival for patients with multiple myeloma

ASCO 2016: Lenalidomide maintenance therapy improves overall survival for patients with multiple myeloma

ASCO 2016: Durvalumab monotherapy demonstrates efficacy in urothelial bladder cancer

ASCO 2016: Durvalumab monotherapy demonstrates efficacy in urothelial bladder cancer

ASCO 2016: Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery

ASCO 2016: Chemotherapy combination with capecitabine extends survival after pancreatic cancer surgery

ASCO 2016: Cancer drug retail prices vastly different between countries

ASCO 2016: Cancer drug retail prices vastly different between countries

ASCO 2016: Novel daratumumab-based regimen slows multiple myeloma progression

ASCO 2016: Novel daratumumab-based regimen slows multiple myeloma progression

ASCO 2016: Antibody drug conjugate shows early promise in small cell lung cancer

ASCO 2016: Antibody drug conjugate shows early promise in small cell lung cancer

ASCO 2016: Novel antibody helps patients with advanced gastric cancer live longer

ASCO 2016: Novel antibody helps patients with advanced gastric cancer live longer

ASCO 2016: Liquid biopsy may help guide treatment decisions for advanced solid tumours

ASCO 2016: Liquid biopsy may help guide treatment decisions for advanced solid tumours

ASCO 2016: Precision medicine approach may expand therapeutic options for patients

ASCO 2016: Precision medicine approach may expand therapeutic options for patients

ASCO 2016: Chemotherapy improves outcomes for certain patients with rare brain cancer

ASCO 2016: Chemotherapy improves outcomes for certain patients with rare brain cancer

More from ecancer